Immunocore Holdings plc ( IMCR) - Stock Earnings
IMCR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
IMCR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -22.3 million USD | 77.4 million USD |
| 2026Q1 | 13.0 million USD | 106.7 million USD |
| 2026Q2 | -808000 USD | 115.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IMCR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -43.8 million USD | 197.4 million USD |
| 2024 | -40.8 million USD | 248.0 million USD |
| 2025 | -26.4 million USD | 297.6 million USD |
| 2026 Est. | — | — |
IMCR
Price: $29.55
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 522338
Market Capitalization: 1.5 billion